Immunovant Inc. Common Stock vs Keurig Dr Pepper Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Keurig Dr Pepper Inc. Common Stock trades at $31.22 (market cap $41.56B). The key difference: Keurig Dr Pepper Inc. Common Stock is far larger — about 6.3× Immunovant Inc. Common Stock's market cap, and Keurig Dr Pepper Inc. Common Stock pays a 3.01% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Keurig Dr Pepper Inc. Common Stock for 0 Days on average.
| IMVT | KDP | |
|---|---|---|
Market Cap | $6.62B | $41.56B |
Volume | 1,131,364 | 7,039,732 |
Sector | Health | Consumer Staples |
52-Week High | $44.96 | $33.50 |
52-Week Low | $17.03 | $25.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $70.02B |
Dividend Yield | — | 3.01% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Keurig Dr Pepper produces and distributes coffee, soft drinks, juices, and other beverages. It also operates the Keurig single-serve coffee system.
Read more on KDP →